{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:03:25Z","timestamp":1781625805663,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infections have been associated with a greater risk of Alzheimer\u2019s disease and related dementias (ADRD), but it is unclear how infections influence structural brain patterns over time, and whether post-infection brain atrophy can accelerate cognitive decline and molecular changes underlying dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using the Baltimore Longitudinal Study of Aging (BLSA;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009793; mean age\u2009=\u200970.1), we examined how infections relate to longitudinal changes in machine learning-derived, 3\u00a0T-MRI neuroimaging signatures, and leveraged the UK Biobank (UKB; 1,120; mean age\u2009=\u200962.9 yrs) to externally validate infection-brain atrophy relationships. Using the BLSA, we also asked if infection history and infection-related brain volume loss were associated with cognitive decline, amyloid-beta PET, and ADRD plasma biomarker trajectories (A\u03b2\n                      <jats:sub>42\/40<\/jats:sub>\n                      , pTau-181, NfL, GFAP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We detected accelerated parieto-temporal atrophy in BLSA participants with a history of upper respiratory tract, bacterial, and urinary tract infections (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), as well as influenza and skin\/subcutaneous infections (FDR\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). After demonstrating their associations with longitudinal neuroimaging signatures in the UKB and prevalent dementia in the BLSA, we found that infections were related to a greater burden of ADRD plasma biomarkers and accelerated rates of cognitive decline in BLSA participants. Integrating longitudinal brain scans, cognitive assessments, and plasma biomarker measurements, we identified infection-related changes in verbal memory and NfL that were more prominent among BLSA participants who experienced greater post-infection brain atrophy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Along with demonstrating that infections mediate clinically relevant brain atrophy patterns, these findings highlight the consequences of post-infection brain volume loss on longitudinal neurocognitive outcomes and extend our understanding of the biological basis by which infections may contribute to neurodegeneration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01924-2","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:05:24Z","timestamp":1764921924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-infection brain atrophy accelerates cognitive and molecular changes underlying dementia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1029-4423","authenticated-orcid":false,"given":"Michael R.","family":"Duggan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyry N.","family":"Sipil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guray","family":"Erus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Bilgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Moghekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kivim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"11","key":"1924_CR1","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","volume":"21","author":"PN Sipil\u00e4","year":"2021","unstructured":"Sipil\u00e4 PN, Heikkil\u00e4 N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, et al. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis. 2021;21(11):1557\u201367.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1924_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40588-021-00168-6","volume":"8","author":"L Butler","year":"2021","unstructured":"Butler L, Walker KA. The role of chronic infection in Alzheimer\u2019s disease: instigators, co-conspirators, or bystanders? Curr Clin Microbiol Rep. 2021;8(4):199\u2013212.","journal-title":"Curr Clin Microbiol Rep"},{"issue":"7907","key":"1924_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697\u2013707.","journal-title":"Nature"},{"key":"1924_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201036","author":"MR Duggan","year":"2022","unstructured":"Duggan MR, Peng Z, An Y, Kitner Triolo MH, Shafer AT, Davatzikos C, et al. Herpes viruses in the Baltimore Longitudinal Study of Aging: associations with brain volumes, cognitive performance, and plasma biomarkers. Neurology. 2022. https:\/\/doi.org\/10.1212\/WNL.0000000000201036.","journal-title":"Neurology"},{"key":"1924_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00682-4","author":"MR Duggan","year":"2024","unstructured":"Duggan MR, Peng Z, Sipil\u00e4 PN, Lindbohm JV, Chen J, Lu Y, et al. Proteomics identifies potential immunological drivers of post-infection brain atrophy and cognitive decline. Nat Aging. 2024. https:\/\/doi.org\/10.1038\/s43587-024-00682-4.","journal-title":"Nat Aging"},{"issue":"12","key":"1924_CR6","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/cid\/cix1124","volume":"66","author":"JH Cole","year":"2018","unstructured":"Cole JH, Caan MWA, Underwood J, De Francesco D, van Zoest RA, Wit F, et al. No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project. Clin Infect Dis. 2018;66(12):1899\u2013909.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1924_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/QAD.0000000000002436","volume":"34","author":"KJ Kallianpur","year":"2020","unstructured":"Kallianpur KJ, Jahanshad N, Sailasuta N, Benjapornpong K, Chan P, Pothisri M, et al. Regional brain volumetric changes despite 2 years of treatment initiated during acute HIV infection. AIDS. 2020;34(3):415\u201326.","journal-title":"AIDS"},{"issue":"11","key":"1924_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/acn3.51669","volume":"9","author":"C Warren-Gash","year":"2022","unstructured":"Warren-Gash C, Cadogan SL, Nicholas JM, Breuer JM, Shah D, Pearce N, et al. Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the dominantly inherited Alzheimer network. Ann Clin Transl Neurol. 2022;9(11):1727\u201338.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"1924_CR9","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/s41591-024-03144-x","volume":"30","author":"Z Yang","year":"2024","unstructured":"Yang Z, Wen J, Erus G, Govindarajan ST, Melhem R, Mamourian E, et al. Brain aging patterns in a large and diverse cohort of 49,482 individuals. Nat Med. 2024;30(10):3015\u201326.","journal-title":"Nat Med"},{"issue":"5","key":"1924_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/alz.12556","volume":"18","author":"JA Frontera","year":"2022","unstructured":"Frontera JA, Boutajangout A, Masurkar AV, Betensky RA, Ge Y, Vedvyas A, et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer\u2019s dementia. Alzheimer\u2019s & Dementia. 2022;18(5):899\u2013910.","journal-title":"Alzheimer's & Dementia"},{"issue":"22","key":"1924_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt7176","volume":"11","author":"MR Duggan","year":"2025","unstructured":"Duggan MR, Yang S, Gomez GT, Cui Y, Capuano AW, Chen J, et al. Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration. Sci Adv. 2025;11(22):eadt7176.","journal-title":"Sci Adv"},{"key":"1924_CR12","volume-title":"Normal human aging: the Baltimore longitudinal study of aging","author":"NW Shock","year":"1984","unstructured":"Shock NW, Greulich RC, Aremberg D, Costa PT, Lakatta EG, Tobin JD. Normal human aging: the Baltimore longitudinal study of aging. Washington, D.C.: National Institutes of Health; 1984."},{"issue":"12","key":"1924_CR13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jamaneurol.2021.3895","volume":"78","author":"NM Cocoros","year":"2021","unstructured":"Cocoros NM, Svensson E, Sz\u00e9pligeti SK, Vestergaard SV, Szentk\u00fati P, Thomsen RW, et al. Long-term risk of Parkinson disease following influenza and other infections. JAMA Neurol. 2021;78(12):1461\u201370.","journal-title":"JAMA Neurol"},{"issue":"7","key":"1924_CR14","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1016\/S2666-7568(21)00118-5","volume":"2","author":"R Muzambi","year":"2021","unstructured":"Muzambi R, Bhaskaran K, Smeeth L, Brayne C, Chaturvedi N, Warren-Gash C. Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study. Lancet Healthy Longev. 2021;2(7):e426-35.","journal-title":"Lancet Healthy Longev"},{"key":"1924_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.11.073","volume":"127","author":"J Doshi","year":"2016","unstructured":"Doshi J, Erus G, Ou Y, Resnick SM, Gur RC, Gur RE, et al. MUSE: multi-atlas region segmentation utilizing ensembles of registration algorithms and parameters, and locally optimal atlas selection. Neuroimage. 2016;127:186\u201395.","journal-title":"Neuroimage"},{"issue":"8","key":"1924_CR16","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1523\/JNEUROSCI.23-08-03295.2003","volume":"23","author":"SM Resnick","year":"2003","unstructured":"Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci. 2003;23(8):3295\u2013301.","journal-title":"J Neurosci"},{"key":"1924_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13157","author":"M Bilgel","year":"2023","unstructured":"Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, Kac PR, et al. Longitudinal changes in Alzheimer\u2019s-related plasma biomarkers and brain amyloid. Alzheimers Dement. 2023. https:\/\/doi.org\/10.1002\/alz.13157.","journal-title":"Alzheimers Dement"},{"key":"1924_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neuroimage.2017.10.034","volume":"166","author":"F Alfaro-Almagro","year":"2018","unstructured":"Alfaro-Almagro F, Jenkinson M, Bangerter NK, Andersson JLR, Griffanti L, Douaud G, et al. Image processing and quality control for the first 10,000 brain imaging datasets from UK biobank. Neuroimage. 2018;166:400\u201324.","journal-title":"Neuroimage"},{"issue":"5","key":"1924_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/bimj.200710464","volume":"50","author":"A Dmitrienko","year":"2008","unstructured":"Dmitrienko A, Tamhane AC, Wiens BL. General multistage gatekeeping procedures. Biom J. 2008;50(5):667\u201377.","journal-title":"Biom J"},{"key":"1924_CR20","doi-asserted-by":"crossref","unstructured":"Zhijian Y, Junhao W, Guray E, Sindhuja TG, Randa M, Elizabeth M, et al. Brain aging patterns in a large and diverse cohort of 49,482 individuals. Nature Medicine. 2024;30(10):3015-26.","DOI":"10.1038\/s41591-024-03144-x"},{"issue":"1","key":"1924_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00627-2","volume":"18","author":"KA Walker","year":"2023","unstructured":"Walker KA, Le Page LM, Terrando N, Duggan MR, Heneka MT, Bettcher BM. The role of peripheral inflammatory insults in Alzheimer\u2019s disease: a review and research roadmap. Mol Neurodegener. 2023;18(1):37.","journal-title":"Mol Neurodegener"},{"key":"1924_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08800-x","author":"M Eyting","year":"2025","unstructured":"Eyting M, Xie M, Michalik F, He\u00df S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025. https:\/\/doi.org\/10.1038\/s41586-025-08800-x.","journal-title":"Nature"},{"issue":"2","key":"1924_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41380-019-0609-8","volume":"25","author":"Y-L Tan","year":"2020","unstructured":"Tan Y-L, Yuan Y, Tian L. Microglial regional heterogeneity and its role in the brain. Mol Psychiatry. 2020;25(2):351\u201367.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1924_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12979-022-00302-y","volume":"19","author":"T Nevalainen","year":"2022","unstructured":"Nevalainen T, Autio A, Hurme M. Composition of the infiltrating immune cells in the brain of healthy individuals: effect of aging. Immunity Ageing. 2022;19(1):45.","journal-title":"Immunity Ageing"},{"issue":"5","key":"1924_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neuron.2019.07.015","volume":"103","author":"MD Cain","year":"2019","unstructured":"Cain MD, Salimi H, Diamond MS, Klein RS. Mechanisms of pathogen invasion into the central nervous system. Neuron. 2019;103(5):771\u201383.","journal-title":"Neuron"},{"issue":"11","key":"1924_CR26","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I. The blood\u2013brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021;18(11):2489\u2013501.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1924_CR27","doi-asserted-by":"publisher","first-page":"15015","DOI":"10.1038\/srep15015","volume":"5","author":"D Pisa","year":"2015","unstructured":"Pisa D, Alonso R, R\u00e1bano A, Rodal I, Carrasco L. Different brain regions are infected with fungi in Alzheimer\u2019s disease. Sci Rep. 2015;5(1):15015.","journal-title":"Sci Rep"},{"issue":"4","key":"1924_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/alz.12399","volume":"18","author":"HS Yang","year":"2022","unstructured":"Yang HS, Zhang C, Carlyle BC, Zhen SY, Trombetta BA, Schultz AP, et al. Plasma IL-12\/IFN-\u03b3 axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimer\u2019s & Dementia. 2022;18(4):645\u201353.","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"1924_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol. 2014;50(2):534\u201344.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"1924_CR30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.neurobiolaging.2009.10.012","volume":"32","author":"JL Whitwell","year":"2011","unstructured":"Whitwell JL, Jack CR Jr., Przybelski SA, Parisi JE, Senjem ML, Boeve BF, et al. Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging. 2011;32(9):1531\u201341.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1924_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, et al. Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by Herpesviridae to protect against brain infection. Neuron. 2018;99(1):56-63.e3.","journal-title":"Neuron"},{"key":"1924_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061430","author":"M Puthia","year":"2022","unstructured":"Puthia M, Marzinek JK, Petruk G, Ert\u00fcrk Bergdahl G, Bond PJ, Petrlova J. Antibacterial and anti-inflammatory effects of Apolipoprotein E. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10061430.","journal-title":"Biomedicines"},{"issue":"4","key":"1924_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Su\u00e1rez-Calvet M, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol. 2022;21(4):329\u201341.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1924_CR34","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain. 2017;140(3):792\u2013803.","journal-title":"Brain"},{"issue":"11","key":"1924_CR35","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","volume":"33","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA, et al. Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci. 2013;33(11):5053\u201364.","journal-title":"J Neurosci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01924-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01924-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01924-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:02:59Z","timestamp":1781622179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01924-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01924-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The BLSA protocol was approved by the Institutional Review Board (IRB) of the National Institute of Environmental Health Science, National Institutes of Health (NIH) (03AG0325), and all participants gave written informed consent prior to participation. The UKB study was approved by the National Health Service National Research Ethics Service (11\/NW\/0382) and all participants gave informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript, agreed to its content, and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K.A.W. is an Associate Editor at Alzheimer\u2019s & Dementia, a member of the Editorial Board of Annals of Clinical and Translational Neurology, and on the Board of Directors of the National Academy of Neuropsychology. All other authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}